Real-time enrollment status for this endometrial cancer clinical trial
Current Status
Recruiting
Checked: September 3, 2026 at 5:13 AM UTC
| NCT Number | NCT07044336 |
| Recruiting Status | Recruiting |
| Condition | Endometrial Cancer |
| Phase | PHASE3 |
| Target Enrollment | 800 participants |
| Active Locations | 69 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | July 29, 2026 (Jul 29, 2026) |
As of September 3, 2026: Clinical trial NCT07044336 is currently recruiting participants. This phase3 study for endometrial cancer is actively seeking new participants at 69 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07044336 is actively recruiting participants as of September 3, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 69 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07044336 was last updated Jul 29, 2026 (July 29, 2026). HelloStudys verifies this status automatically.